Utah’s medical cannabis market continued its steady growth in August, generating $14.8 million in sales, bringing the year-to-date total to $116 million, according to the state’s latest monthly report.
The report shows that cartridges and vape pens led the way, accounting for roughly $7.1 million in sales. Flower followed at $4.8 million, while edibles brought in about $2.65 million. Topical and other infused non-edibles contributed just over $115,000, with non-medicated items such as vaporizers and grinders adding nearly $120,000.
As of August, Utah had 103,736 registered patients with active medical cannabis cards, around 10,000 more than at the start of the year, highlighting the program’s rapid expansion since its launch. The largest share of patients fell in the 31–40 age group, making up more than 26% of cardholders, followed by 22% aged 41–50 and nearly 22% aged 21–30. Seniors over 65 represented 11% of patients.
Patient activity remained robust. In the past 30 days, more than 57,000 patients made at least one purchase, while nearly 20,000 bought cannabis products on three or more occasions.
On the production side, Utah cultivators harvested more than 13.9 million grams of cannabis biomass in August, drawn from nearly 24,000 plants across 247 planting batches. Licensed processors manufactured a wide range of products from this supply, including nearly 800,000 grams of buds and more than 892,000 grams of trim for derivative products. Pharmacies received over 143,000 vape cartridges, 83,800 flower packages, and nearly 80,000 edible units for patient sale.
Delivery also played a growing role, with multiple companies providing home and courier options across urban and rural counties. Pickups—orders placed online and retrieved in person—remained a central distribution method as well.
The report further noted that Utah now has 997 recommending medical providers registered through the state’s electronic system, with another 202 still operating under paper-only recommendations. Salt Lake County continues to serve as the hub of the program, with more than 42,000 patients and nearly half of the state’s recommending providers.
Regulatory oversight remained active, with 22 inspections conducted at cultivation, processing, and pharmacy sites. Violations included issues with inventory control, security standards, and labeling requirements.
Utah’s medical cannabis program, overseen jointly by the Department of Health and Human Services and the Department of Agriculture and Food, has seen consistent growth in both patient participation and sales since it first launched dispensaries in March 2020.
